Bliss GVS Pharma Announces 41st AGM on July 15, 2026, via VC/OAVM
Bliss GVS Pharma Limited will hold its 41st Annual General Meeting on July 15, 2026, at 11:00 a.m. IST. The meeting will be conducted via Video Conferencing (VC)/Other Audio Visual Means (OAVM). Newspaper notices were published on June 19, 2026.
This is a standard procedural announcement regarding the AGM, which is a regular corporate event and typically has a low immediate impact on the company's stock unless specific significant proposals are being discussed.
The announcement is a routine intimation about the upcoming Annual General Meeting and does not contain any financial performance or strategic updates that would sway sentiment.
Bliss GVS Pharma Limited has submitted copies of newspaper notices regarding its 41st Annual General Meeting (AGM). The AGM is scheduled to be held on Wednesday, July 15, 2026, commencing at 11:00 a.m. (IST).
The meeting will be conducted through Video Conferencing (VC) and Other Audio Visual Means (OAVM), in compliance with relevant SEBI and Ministry of Corporate Affairs (MCA) circulars. The notices were published on June 19, 2026, in "The Economic Times", "Free Press Journal", "Maharashtra Times", and "Navshakti". This announcement is made pursuant to Regulation 30 and Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
What to do with a filing like this
Bliss GVS Pharma Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Bliss GVS Pharma Limited. Read the original for the full detail.